facebook  linkedin xpix

Diary Dates
Save the date for important iCMLf meetings and programs
calendar

Become a member

Become an iCMLf member - help shape our future
member-button

Please donate

Support our activities
by donating
Donate here

Supporters

We thank all our supporters and partners

supporter-lay2

If you are not a member, please click on "Register". If you have forgotten your password, please click on "Forgot login?" below.

Welcome to the Website of the

International Chronic Myeloid Leukemia Foundation (iCMLf)


The iCMLf is a charitable foundation established in 2009  by a group of hematologists with a strong interest in Chronic Myeloid Leukemia (CML). The mission of the iCMLf is to improve the outcomes for patients with CML globally. Working with physicians treating CML and the CML scientific community the Foundation aims to foster and coordinate global clinical and research collaborations and to improve clinical practice and disease monitoring in CML around the world. Scientific advisors and national representatives spanning over 30 countries provide guidance and advice to further the aims of the iCMLf.

Read more about the iCMLf here

Latest News:

Programs

VEP Mahon

View new presentations on the Virtual Education Program

Three new online presentations have recently been added to the Virtual Education Program. Again we were able to engage leaders in the field of CML to talk about the latest scientific findings on the management of CML. View the following new presentations featuring: Stopping TKI therapy in Chronic Myeloid Leukemia Francois-Xavier Mahon,… read more ...

iCMLf

iCMLf Newsletter June 16 cover

iCMLf Newsletter June 2016 now available

The new edition of the iCMLf Newsletter features; iCMLf Clinical Preceptorship Program - offering long-lasting benefits, new iCMLf educational news services - covering the latest advances in CML, CML story published in Blood - CML treatment-free remission critieria outlined, iCMLf Prizes -… read more ...

Education

EHA 2016

CML Highlights from EHA 2016 - an overview

CML news was among the highlights of the 21st Congress of the European Hematology Association (EHA) in Copenhagen last month including data supporting the discontinuation of TKI therapy in chronic-phase CML. We have compiled a selection of these CML… read more ...